(19)
(11) EP 2 361 058 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.08.2020 Bulletin 2020/34

(45) Mention of the grant of the patent:
08.07.2020 Bulletin 2020/28

(21) Application number: 09752524.0

(22) Date of filing: 06.11.2009
(51) International Patent Classification (IPC): 
A61F 2/07(2013.01)
A61F 2/91(2013.01)
 A61F 2/89(2013.01)
(86) International application number:
PCT/US2009/005997
(87) International publication number:
WO 2010/053563 (14.05.2010 Gazette 2010/19)

(54)

STENT MEMBER

STENTELEMENT

ÉLÉMENT D'ENDOPROTHÈSE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 06.11.2008 GB 0820360

(43) Date of publication of application:
31.08.2011 Bulletin 2011/35

(73) Proprietor: Cook Medical Technologies LLC
Bloomington, IN 47404 (US)

(72) Inventors:
  • RASMUSSEN, Erik
    4200 Slagelse (DK)
  • JENSEN, Kim Moegelvang
    2450 Koevenhavn SV (DK)

(74) Representative: Powell, Stephen David 
Williams Powell Staple Court 11 Staple Inn Buildings
London, WC1V 7QH
London, WC1V 7QH (GB)


(56) References cited: : 
EP-A2- 0 808 614
WO-A1-2010/030928
 WO-A1-00/28922
US-A1- 2004 186 551
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).